{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:08:18Z","timestamp":1761520098784,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.clcc.2012.11.005","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T21:32:00Z","timestamp":1357767120000},"page":"152-162.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adenovirus-Mediated Transcriptional Targeting of Colorectal Cancer and Effects on Treatment-Resistant Hypoxic Cells"],"prefix":"10.1016","volume":"12","author":[{"given":"Simon","family":"Rajendran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald C.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre","family":"O'Hanlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Tangney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2012.11.005_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrclinonc.2009.65","article-title":"Medical oncology: multimodality therapy in unresectable colorectal cancer","volume":"6","author":"Popowich","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clcc.2012.11.005_bib4","first-page":"128","article-title":"Optimal timing of surgery after preoperative chemoradiotherapy for rectal cancer","volume":"6","author":"P\u00e5hlman","year":"2009","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.clcc.2012.11.005_bib5","first-page":"1213","article-title":"Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck","volume":"31","author":"Zhu","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.clcc.2012.11.005_bib6","doi-asserted-by":"crossref","first-page":"R1141","DOI":"10.1186\/bcr1353","article-title":"Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system","volume":"7","author":"Stoff-Khalili","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clcc.2012.11.005_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.clcc.2012.11.005_bib8","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/jnci\/dji431","article-title":"Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer","volume":"97","author":"Kaifi","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2012.11.005_bib9","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1158\/0008-5472.CAN-05-3393","article-title":"Role of the CXCL12\/CXCR4 axis in peritoneal carcinomatosis of gastric cancer","volume":"66","author":"Yasumoto","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2012.11.005_bib10","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/sj.bjc.6600221","article-title":"CXCR4\/CXCL12 expression and signalling in kidney cancer","volume":"86","author":"Schrader","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2012.11.005_bib11","first-page":"3833","article-title":"The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases","volume":"63","author":"Zeelenberg","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2012.11.005_bib12","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1158\/1078-0432.CCR-05-2142","article-title":"Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients","volume":"12","author":"Ottaiano","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2012.11.005_bib13","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1158\/1078-0432.CCR-04-1195","article-title":"Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer","volume":"11","author":"Schimanski","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2012.11.005_bib14","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1200\/JCO.2005.07.078","article-title":"Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival","volume":"23","author":"Kim","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2012.11.005_bib15","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.addr.2009.04.017","article-title":"Hypoxia targeting gene expression for breast cancer gene therapy","volume":"61","author":"Lee","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"13 spec no","key":"10.1016\/j.clcc.2012.11.005_bib16","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0959-8049(00)00159-3","article-title":"Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation","volume":"36","author":"Dachs","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2012.11.005_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","article-title":"Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy","volume":"77","author":"Nordsmark","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2012.11.005_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0959-8049(01)00361-6","article-title":"Hypoxia as a target for combined modality treatments","volume":"38","author":"Wouters","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2012.11.005_bib19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1054\/bjoc.2000.1318","article-title":"Gene delivery to hypoxic cells in vitro","volume":"83","author":"Dachs","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2012.11.005_bib20","doi-asserted-by":"crossref","DOI":"10.3791\/2378-v","article-title":"Ex vivo culture of patient tissue & examination of gene delivery","author":"Rajendran","year":"2010","journal-title":"J Vis Exp"},{"key":"10.1016\/j.clcc.2012.11.005_bib21","first-page":"1627","article-title":"Targeting of breast metastases using a viral gene vector with tumour-selective transcription","volume":"31","author":"Rajendran","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clcc.2012.11.005_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/hum.2009.022","article-title":"A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy","volume":"21","author":"van Pijkeren","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.clcc.2012.11.005_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1258\/ebm.2011.010234","article-title":"Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer","volume":"236","author":"Rajendran","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.clcc.2012.11.005_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.clcc.2012.11.005_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.gt.3302089","article-title":"Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter","volume":"11","author":"Zhu","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.clcc.2012.11.005_bib26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/mt.2009.66","article-title":"Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth","volume":"17","author":"Ahmad","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.clcc.2012.11.005_bib27","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.ejca.2005.01.025","article-title":"Combined electric field and ultrasound therapy as a novel anti-tumour treatment","volume":"41","author":"Larkin","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2012.11.005_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1479-0556-7-5","article-title":"Anti-metastatic effects of viral and non-viral mediated Nk4 delivery to tumours","volume":"7","author":"Buhles","year":"2009","journal-title":"Genet Vaccines Ther"},{"key":"10.1016\/j.clcc.2012.11.005_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1258\/ebm.2011.010234","article-title":"Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer","volume":"236","author":"Rajendran","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.clcc.2012.11.005_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/mthe.2002.0670","article-title":"Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells","volume":"6","author":"Barnett","year":"2002","journal-title":"Mol Ther"},{"key":"10.1016\/j.clcc.2012.11.005_bib31","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1158\/0008-5472.CAN-04-1844","article-title":"CXCR4 regulates growth of both primary and metastatic breast cancer","volume":"64","author":"Smith","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2012.11.005_bib32","doi-asserted-by":"crossref","first-page":"15911","DOI":"10.1074\/jbc.M300463200","article-title":"Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha","volume":"278","author":"Yuan","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clcc.2012.11.005_bib33","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1242\/jeb.201.8.1153","article-title":"Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression","volume":"201","author":"Ratcliffe","year":"1998","journal-title":"J Exp Biol"},{"key":"10.1016\/j.clcc.2012.11.005_bib34","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ki.1997.79","article-title":"Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level","volume":"51","author":"Wenger","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.clcc.2012.11.005_bib35","first-page":"468","article-title":"Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase activation in human cervical cancer HeLa cells","volume":"36","author":"Kim","year":"2003","journal-title":"J Biochem Mol Biol"},{"key":"10.1016\/j.clcc.2012.11.005_bib36","first-page":"480","article-title":"Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase 1\/2 activation in rat C6 glioma cells","volume":"37","author":"Yang","year":"2004","journal-title":"J Biochem Mol Biol"},{"key":"10.1016\/j.clcc.2012.11.005_bib37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0360-3016(95)00106-9","article-title":"Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases","volume":"32","author":"Brizel","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2012.11.005_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ijc.2910630121","article-title":"Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid","volume":"63","author":"Hill","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2012.11.005_bib39","series-title":"Gene Therapy - Developments and Future Perspectives","first-page":"247","article-title":"Comparison of DNA delivery and expression using frequently used delivery methods","author":"Collins","year":"2011"},{"key":"10.1016\/j.clcc.2012.11.005_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/ten.tec.2008.0323","article-title":"Comparison of viral and nonviral vectors for gene transfer to human endothelial progenitor cells","volume":"15","author":"Kealy","year":"2009","journal-title":"Tissue Eng Part C Methods"},{"key":"10.1016\/j.clcc.2012.11.005_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/156652308784049345","article-title":"Viral vectors in cancer immunotherapy: which vector for which strategy?","volume":"8","author":"Collins","year":"2008","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.clcc.2012.11.005_bib42","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2012.11.005_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1600-065X.2000.17715.x","article-title":"CXCR4: chemokine receptor extraordinaire","volume":"177","author":"Murdoch","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clcc.2012.11.005_bib44","first-page":"1","article-title":"In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma","volume":"55","author":"Clayman","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2012.11.005_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jcp.10374","article-title":"How to overcome (and exploit) tumor hypoxia for targeted gene therapy","volume":"197","author":"Greco","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.clcc.2012.11.005_bib46","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1182\/blood.V92.7.2260","article-title":"Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha","volume":"92","author":"Wiesener","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clcc.2012.11.005_bib47","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/JVI.73.2.1309-1319.1999","article-title":"Cloning and characterization of adeno-associated virus type 5","volume":"73","author":"Chiorini","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.clcc.2012.11.005_bib48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ilar.49.1.103","article-title":"Noninvasive bioluminescence imaging in small animals","volume":"49","author":"Zinn","year":"2008","journal-title":"Ilar J"},{"key":"10.1016\/j.clcc.2012.11.005_bib49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2010.08.010","article-title":"An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations","volume":"407","author":"Murakami","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.clcc.2012.11.005_bib50","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gut.44.6.800","article-title":"Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure","volume":"44","author":"Wirtz","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.clcc.2012.11.005_bib51","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.gt.3302448","article-title":"Effect of hypoxia on Ad5 infection, transgene expression and replication","volume":"12","author":"Shen","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.clcc.2012.11.005_bib52","first-page":"353","article-title":"The potential impact of hypoxia on the success of oncolytic virotherapy","volume":"7","author":"Hay","year":"2005","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.clcc.2012.11.005_bib53","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.gt.3302459","article-title":"Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression","volume":"12","author":"Pipiya","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.clcc.2012.11.005_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/VAAT.S17832","article-title":"The impact of hypoxia on oncolytic virotherapy","volume":"3","author":"Guo","year":"2011","journal-title":"Virus Adaptation Treat"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002812001466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002812001466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:02:19Z","timestamp":1761519739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002812001466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1533002812001466"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2012.11.005","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus-Mediated Transcriptional Targeting of Colorectal Cancer and Effects on Treatment-Resistant Hypoxic Cells","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2012.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}